Literature DB >> 27342733

Enhanced Steatosis and Fibrosis in Liver of Adult Offspring Exposed to Maternal High-Fat Diet.

Michael D Thompson1, Mary J Cismowski, Aaron J Trask, Scott W Lallier, Amanda E Graf, Lynette K Rogers, Pamela A Lucchesi, David R Brigstock.   

Abstract

Early life exposures can increase the risk of developing chronic diseases including nonalcoholic fatty liver disease. Maternal high-fat diet increases susceptibility to development of steatosis in the offspring. We determined the effect of maternal high-fat diet exposure in utero and during lactation on offspring liver histopathology, particularly fibrosis. Female C57Bl/6J mice were fed a control or high-fat diet (HFD) for 8 weeks and bred with lean males. Nursing dams were continued on the same diet with offspring sacrificed during the perinatal period or maintained on either control or high-fat diet for 12 weeks. Increased hepatocyte proliferation and stellate cell activation were observed in the liver of HFD-exposed pups. Offspring exposed to perinatal high-fat diet and high-fat diet postweaning showed extensive hepatosteatosis compared to offspring on high-fat diet after perinatal control diet. Offspring exposed to perinatal high-fat diet and then placed on control diet for 12 weeks developed steatosis and pericellular fibrosis. Importantly, we found that exposure to perinatal high-fat diet unexpectedly promotes more rapid disease progression of nonalcoholic fatty liver disease, with a sustained fibrotic phenotype, only in adult offspring fed a postweaning control diet.

Entities:  

Mesh:

Year:  2016        PMID: 27342733      PMCID: PMC5611859          DOI: 10.3727/105221616X692135

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  37 in total

Review 1.  Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review.

Authors:  Rex T Wang; Ronald L Koretz; Hal F Yee
Journal:  Am J Med       Date:  2003-11       Impact factor: 4.965

2.  Prepregnancy obesity trends among low-income women, United States, 1999-2008.

Authors:  Stefanie N Hinkle; Andrea J Sharma; Shin Y Kim; Sohyun Park; Karen Dalenius; Patricia L Brindley; Laurence M Grummer-Strawn
Journal:  Matern Child Health J       Date:  2012-10

3.  Oxidative stress induced lipocalin 2 gene expression: addressing its expression under the harmful conditions.

Authors:  Mehryar Habibi Roudkenar; Yoshikazu Kuwahara; Taisuke Baba; Amaneh Mohammadi Roushandeh; Shigeko Ebishima; Shinya Abe; Yasuhito Ohkubo; Manabu Fukumoto
Journal:  J Radiat Res       Date:  2007-01-16       Impact factor: 2.724

4.  Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells.

Authors:  A Galli; D Crabb; D Price; E Ceni; R Salzano; C Surrenti; A Casini
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

5.  Fetal and placental size and risk of hypertension in adult life.

Authors:  D J Barker; A R Bull; C Osmond; S J Simmonds
Journal:  BMJ       Date:  1990-08-04

Review 6.  Fetal nutrition and cardiovascular disease in adult life.

Authors:  D J Barker; P D Gluckman; K M Godfrey; J E Harding; J A Owens; J S Robinson
Journal:  Lancet       Date:  1993-04-10       Impact factor: 79.321

7.  Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease.

Authors:  Valerio Nobili; Guido Carpino; Anna Alisi; Antonio Franchitto; Gianfranco Alpini; Rita De Vito; Paolo Onori; Domenico Alvaro; Eugenio Gaudio
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

8.  Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.

Authors:  Elizabeth M Brunt; David E Kleiner; Laura A Wilson; Aynur Unalp; Cynthia E Behling; Joel E Lavine; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

9.  Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.

Authors:  Wing-Kin Syn; Steve S Choi; Evaggelia Liaskou; Gamze F Karaca; Kolade M Agboola; Ye Htun Oo; Zhiyong Mi; Thiago A Pereira; Marzena Zdanowicz; Padmini Malladi; Yuping Chen; Cynthia Moylan; Youngmi Jung; Syamal D Bhattacharya; Vanessa Teaberry; Alessia Omenetti; Manal F Abdelmalek; Cynthia D Guy; David H Adams; Paul C Kuo; Gregory A Michelotti; Peter F Whitington; Anna Mae Diehl
Journal:  Hepatology       Date:  2010-10-21       Impact factor: 17.425

10.  Oxidative stress and altered lipid homeostasis in the programming of offspring fatty liver by maternal obesity.

Authors:  Maria Z Alfaradhi; Denise S Fernandez-Twinn; Malgorzata S Martin-Gronert; Barbara Musial; Abigail Fowden; Susan E Ozanne
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-04-30       Impact factor: 3.619

View more
  17 in total

Review 1.  Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease.

Authors:  Frank T Spradley; Jillian A Smith; Barbara T Alexander; Christopher D Anderson
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-06       Impact factor: 4.310

Review 2.  Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis.

Authors:  Jia-Zhen Zhang; Jing-Jing Cai; Yao Yu; Zhi-Gang She; Hongliang Li
Journal:  Gene Expr       Date:  2019-04-22

3.  Transgenerational impact of maternal obesogenic diet on offspring bile acid homeostasis and nonalcoholic fatty liver disease.

Authors:  Michael D Thompson; Alaina Derse; Jeremie LA Ferey; Michaela Reid; Yan Xie; Miranda Christ; Deyali Chatterjee; Chau Nguyen; Natalia Harasymowicz; Farshid Guilak; Kelle H Moley; Nicholas Oliver Davidson
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-03-12       Impact factor: 4.310

4.  Maternal obesogenic diet regulates offspring bile acid homeostasis and hepatic lipid metabolism via the gut microbiome in mice.

Authors:  Michael D Thompson; Jisue Kang; Austin Faerber; Holly Hinrichs; Oğuz Özler; Jamie Cowen; Yan Xie; Phillip I Tarr; Nicholas O Davidson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-01-05       Impact factor: 4.052

5.  Beneficial effects of exercise on offspring obesity and insulin resistance are reduced by maternal high-fat diet.

Authors:  Juliane Kasch; Sara Schumann; Saskia Schreiber; Susanne Klaus; Isabel Kanzleiter
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

6.  Maternal obesity in pregnancy impacts offspring cardiometabolic health: Systematic review and meta-analysis of animal studies.

Authors:  M D Menting; S Mintjens; C van de Beek; C J Frick; S E Ozanne; J Limpens; T J Roseboom; C R Hooijmans; A W van Deutekom; R C Painter
Journal:  Obes Rev       Date:  2019-01-11       Impact factor: 9.213

Review 7.  Molecular mechanisms governing offspring metabolic programming in rodent models of in utero stress.

Authors:  Efthimia R Christoforou; Amanda N Sferruzzi-Perri
Journal:  Cell Mol Life Sci       Date:  2020-06-03       Impact factor: 9.261

8.  Maternal Exercise Improves Glucose Tolerance in Female Offspring.

Authors:  Kristin I Stanford; Hirokazu Takahashi; Kawai So; Ana Barbara Alves-Wagner; Noah B Prince; Adam C Lehnig; Kristen M Getchell; Min-Young Lee; Michael F Hirshman; Laurie J Goodyear
Journal:  Diabetes       Date:  2017-06-01       Impact factor: 9.461

9.  Maternal obesity during lactation may protect offspring from high fat diet-induced metabolic dysfunction.

Authors:  Jenifer Monks; David J Orlicky; Adrianne L Stefanski; Andrew E Libby; Elise S Bales; Michael C Rudolph; Ginger C Johnson; Vanessa D Sherk; Matthew R Jackman; Kayla Williamson; Nichole E Carlson; Paul S MacLean; James L McManaman
Journal:  Nutr Diabetes       Date:  2018-04-25       Impact factor: 5.097

Review 10.  Developmental Programming of NAFLD by Parental Obesity.

Authors:  Michael D Thompson
Journal:  Hepatol Commun       Date:  2020-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.